Transgenic rabbits as models for atherosclerosis research

Chapman, 1980, Animal lipoproteins: chemistry, structure, and comparative aspects, J. Lipid Res., 21, 789, 10.1016/S0022-2275(20)34780-5 Greeve, 1993, Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing lipoproteins, J. Lipid Res., 34, 1367, 10.1016/S0022-2275(20)36966-2 Nagashima, 1988, Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein, J. Lipid Res., 29, 1643, 10.1016/S0022-2275(20)38413-3 Tall, 1993, Plasma cholesteryl ester transfer protein, J. Lipid Res., 34, 1255, 10.1016/S0022-2275(20)36957-1 Duff, 1935, Experimental cholesterol arteriosclerosis and its relationship to human arteriosclerosis, Arch. Pathol., 20, 81 Clarkson, 1974, Specialized research applications: I. Arteriosclerosis research, 155 Paigen, 1990, Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice, Arteriosclerosis, 10, 316, 10.1161/01.ATV.10.2.316 Borresen, 1978, Partial purification and characterization of the inherited Hl 1 and R 67 antigens of rabbit serum high density lipoprotein, J. Immunogenet, 5, 71, 10.1111/j.1744-313X.1978.tb00633.x Warren, 1991, Rabbit hepatic lipase cDNA sequence: low activity is associated with low messenger RNA levels, J. Lipid Res., 32, 1333, 10.1016/S0022-2275(20)41963-7 Watanabe, 1990, Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit): incidence and development of atherosclerosis and xanthoma, Atherosclerosis, 36, 261, 10.1016/0021-9150(80)90234-8 Tanzawa, 1980, A low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia, FEBS Lett., 18, 81, 10.1016/0014-5793(80)81223-3 La Ville, 1987, Hereditary hyperlipidemia in the rabbit due to overproduction of lipoproteins. I: biochemical studies, Arteriosclerosis, 7, 105, 10.1161/01.ATV.7.2.105 Seddon, 1987, Hereditary hyperlipidemia and atherosclerosis in the rabbit due to overproduction of lipoproteins. II: Preliminary report of arterial pathology, Arteriosclerosis, 7, 113, 10.1161/01.ATV.7.2.113 Perevozchikov, 1993, Study of the effect of the cDNA for the human A-I gene in transgenic rabbits: modeling the neurological syndrome of human Tangier disease, Molekuliarnaia Biologii, 27, 24 Duverger, 1996, Transgenic rabbits expressing human apolipoprotein A-I in the liver, Arterioscler. Thromb. Vasc. Biol., 16, 1424, 10.1161/01.ATV.16.12.1424 Rubin, 1991, Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two high density lipoprotein size subclasses, Proc. Natl. Acad. Sci. USA, 88, 434, 10.1073/pnas.88.2.434 Chao, 1984, Tissue-specific expression of genes encoding apolipoprotein E and A-I in rabbits, J. Biol. Chem., 259, 5306, 10.1016/S0021-9258(17)42990-5 Pan, 1987, Rabbit apolipoprotein A-I mRNA and gene: evidence that rabbit apolipoprotein A-I is synthesized in the intestine but not in the liver, Eur. J. Biochem., 170, 99, 10.1111/j.1432-1033.1987.tb13672.x Duverger, 1996, Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I transgenic rabbits, Circulation, 94, 713, 10.1161/01.CIR.94.4.713 Lebuffe, 1997, Endothelial derived vasorelaxation is impaired in human apoA-I transgenic rabbits, Biochem. Biophys. Res. Commun., 241, 205, 10.1006/bbrc.1997.7790 Cooke, 1992, Antiatherogenic effects of l-arginine in the hypercholesterolemic rabbit, J. Clin. Invest, 90, 1168, 10.1172/JCI115937 Wang, 1994, Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit, J. Am. Coll. Cardiol, 23, 452, 10.1016/0735-1097(94)90433-2 Fan, 1995, Overexpression of human apolipoprotein B-100 in transgenic rabbits results in increased levels of LDL and decreased levels of HDL, Arterioscler. Thromb. Vasc. Biol., 15, 1889, 10.1161/01.ATV.15.11.1889 Linton, 1993, Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a), J. Clin. Invest, 92, 3029, 10.1172/JCI116927 Rouy, 1998, Apolipoprotein(a) yeast artificial chromosome transgenic rabbits, J. Biol. Chem., 273, 1247, 10.1074/jbc.273.2.1247 Callow, 1994, Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice, Proc. Natl. Acad. Sci. USA, 91, 2130, 10.1073/pnas.91.6.2130 Frazer, 1995, The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC mice, Nat. Genet., 9, 424, 10.1038/ng0495-424 Trieu, 1995, The binding of animal low-density lipoproteins to human apolipoprotein(a), Biochem. J., 309, 899, 10.1042/bj3090899 Huang, 1997, Apolipoprotein E2 transgenic rabbits: modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis, J. Biol. Chem., 272, 22685, 10.1074/jbc.272.36.22685 Simonet, 1993, A fardown-stream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice, J. Biol. Chem., 268, 8221, 10.1016/S0021-9258(18)53085-4 Fan, 1998, Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma, J. Clin. Invest, 101, 2151, 10.1172/JCI1599 Choi, 1991, Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo, J. Clin. Invest, 88, 1173, 10.1172/JCI115419 Koo, 1988, Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors, J. Clin. Invest, 81, 1332, 10.1172/JCI113460 Kowal, 1989, Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins, Proc. Natl. Acad. Sci. USA, 86, 5810, 10.1073/pnas.86.15.5810 Ji, 1993, Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells, J. Biol. Chem., 268, 10160, 10.1016/S0021-9258(18)82186-X Taylor, 1997, Transgenic rabbit models for the study of atherosclerosis, Ann. NY Acad. Sci., 811, 146, 10.1111/j.1749-6632.1997.tb51997.x Hoeg, 1993, Development of transgenic Watanabe Heritable Hyperlipidemic rabbits expressing human apolipoprotein A-I, Circulation, 88, I-2 Emmanuel, 1996, Overexpression of human apolipoprotein A-I inhibits atherosclerosis development in Watanabe rabbits, Circulation, 94, I-632 Yamanaka, 1995, Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals, Proc. Natl. Acad. Sci. USA, 92, 8483, 10.1073/pnas.92.18.8483 Yamanaka, 1994, Cloning and mutagenesis of the rabbit apoB mRNA editing protein: a zinc motif is essential for catalytic activity, and noncatalytic auxilliary factor(s) of the editing complex are widely distributed, J. Biol. Chem., 269, 21725, 10.1016/S0021-9258(17)31865-3 Fan, 1994, Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins, Proc. Natl. Acad. Sci. USA, 91, 8724, 10.1073/pnas.91.18.8724 Connelly, 1990, Plasma lipoproteins in familial hepatic lipase deficiency, Arteriosclerosis, 10, 40, 10.1161/01.ATV.10.1.40 Hoeg, 1996, Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits, J. Biol. Chem., 271, 4396, 10.1074/jbc.271.8.4396 Vaisman, 1995, Overexpression of human lecithin cholesterol acyltransferase leads to hyper-alphalipoproteinemia in transgenic mice, J. Biol. Chem., 270, 12269, 10.1074/jbc.270.20.12269 Brousseau, 1996, Hyperalphalipoproteinemia in human lecithin:cholesterol acyltransferase transgenic rabbits: in vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner, J. Clin. Invest, 97, 1844, 10.1172/JCI118614 Brousseau, 1997, Overexpression of LCAT in transgenic rabbits enhances LDL catabolism via the LDL receptor pathway, Circulation, 96, I-230 Hoeg, 1996, Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis, Proc. Natl. Acad. Sci. USA, 93, 11448, 10.1073/pnas.93.21.11448 Brousseau, 1997, Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner, J. Lipid Res., 38, 2537, 10.1016/S0022-2275(20)30038-9 Brousseau, 1998, Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase, J. Lipid Res., 39, 1558, 10.1016/S0022-2275(20)32184-2 Hoeg, 1998, Lecithin:cholesterol acyltransferase requires functional LDL receptors to prevent atherosclerosis, Circulation, 98, I-464 Fan, 1994, Transgenic rabbits overexpressing human hepatic lipase have reduced levels of high density lipoproteins and intermediate density lipoproteins and diminished responses to dietary cholesterol, Circulation, 90, I-289